987 / 1241
Guidelines: RECIST 1.1
New response evaluation criteria in solid tumours: revised
RECIST guideline (version 1.1).
Eisenhauer et al. Eur J Cancer. 2009 Jan;45(2):228-47.
• Assessment of the change in tumour burden is an
important feature of the clinical evaluation of cancer
therapy, both tumour shrinkage and disease progression.
•
It may be appropriate to move from anatomic
assessment of tumour burden to (include) functional
assessment with PET or MRI.
14